Belsomra's price without insurance can vary significantly depending on the pharmacy, dosage, and quantity. However, without insurance, a 30-day supply of Belsomra can cost several hundred dollars. For example, at some pharmacies, a prescription for 30 tablets of 10mg Belsomra might range from approximately $400 to over $600. Prices can fluctuate, and discounts may be available.
What determines the cost of Belsomra?
The cost of Belsomra is influenced by several factors. These include the specific dosage strength prescribed, the quantity of medication dispensed (e.g., a 30-day or 90-day supply), and the retail pricing set by individual pharmacies [1]. Manufacturer coupons or patient assistance programs might also affect the final out-of-pocket expense for individuals without insurance.
Are there ways to get Belsomra at a lower cost?
Patients seeking to reduce the cost of Belsomra without insurance may explore several options. Checking prices at different pharmacies can yield savings, as retail pricing varies. Additionally, the Belsomra manufacturer may offer savings cards or patient assistance programs that can lower out-of-pocket expenses for eligible individuals [2]. Prescription discount cards and websites can also provide access to lower prices.
When does Belsomra's patent expire?
Belsomra (suvorexant) is a medication developed by Merck. Information regarding the specific expiration dates of its primary patents and any related exclusivities can be found on specialized databases like DrugPatentWatch.com, which tracks patent information for pharmaceutical products [3]. Generally, patent protection for drugs aims to provide a period of market exclusivity for the innovator company before generic versions can be introduced.
Can generic Belsomra be made available?
The availability of generic Belsomra depends on the expiration of its patents and the resolution of any legal challenges or market exclusivities. Once patents expire and regulatory hurdles are cleared, other pharmaceutical companies may be able to manufacture and market generic versions of suvorexant. This typically leads to a significant reduction in the drug's price compared to the brand-name version.
What are the common dosages of Belsomra?
Belsomra is available in several dosage strengths, typically ranging from 5 mg to 20 mg [1]. The appropriate dosage is determined by a healthcare provider based on the individual patient's needs and response to treatment. The cost can vary based on the specific dosage strength prescribed.
Who makes Belsomra?
Belsomra is manufactured by Merck & Co., Inc. [2]. It is prescribed for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
What are the potential side effects of Belsomra?
Common side effects associated with Belsomra include drowsiness, dizziness, and somnolence [1]. Less common side effects can also occur. Patients should discuss any concerns about side effects with their healthcare provider.
How does Belsomra work?
Belsomra is a dual orexin receptor antagonist. It works by blocking the activity of orexin, a neurotransmitter that promotes wakefulness [1]. By inhibiting orexin signaling, Belsomra helps to reduce arousal and facilitate sleep.
Where can I find more information about Belsomra's patent status?
For detailed and up-to-date information on Belsomra's patent status, including patent expiration dates and any ongoing litigation, resources such as DrugPatentWatch.com are valuable [3]. These platforms specialize in tracking the intellectual property landscape of pharmaceutical drugs.
---
Sources:
[1] Belsomra Prescribing Information
[2] Merck & Co., Inc.
[3] DrugPatentWatch.com